High materiality7/10
Denali Therapeutics price target raised to $34 from $31 at Baird
Why it may matterVerify against the original reporting
DNLI target upgrade signals upside with priced info.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Baird raises DNLI target to $34; current price $24.73; priceChangeSinceSignal +0.4.
- Baird lifts DNLI target to $34; price $24.73; change +0.4.
Key facts
- 01
Target: $34
- 02
Posted price: $24.73
- 03
Analyst firm: Robert W. Baird
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.